Grants and Contributions:
Title:
JOINTstat™ - German Market Entry
Agreement Number:
907187
Agreement Value:
$23,900.00
Agreement Date:
May 2, 2018 - Oct 31, 2018
Description:
The 14-3-3η JOINTstat test may be used as an aid in the diagnosis of patients with Rheumatoid Arthritis. Augurex plans to commercialize 14-3-3η tests and reagents in Germany to expand our commercial reach.
Organization:
National Research Council Canada
Expected Results:
CanExportCanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Vancouver, British Columbia, CA V5T 4T5
Reference Number:
172-2018-2019-Q1-907187
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
829919521
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 9,900 dollars.
Amendment Date
Oct 17, 2018
Recipient's Legal Name:
Augurex Life Sciences Corp.
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
CanExport
Program Purpose:
CanExportCanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport - CanExport projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
541710
Amendments: